Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.

Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

SEC Filings

SEC Filings

    Filing date Form Description View
    8-K

    Report of unscheduled material events or corporate event

    View HTML
    DEFA14A

    Additional proxy soliciting materials - definitive

    View HTML
    8-K

    Report of unscheduled material events or corporate event

    View HTML
    3

    Initial filing by director officer or owner of more than ten percent.

    View HTML
    4

    Statement of changes in beneficial ownership of securities

    View HTML
    ARS

    An annual report to security holders

    View HTML
    DEF 14A

    Official notification to shareholders of matters to be brought to a vote ("Proxy")

    View HTML
    3

    Initial filing by director officer or owner of more than ten percent.

    View HTML
    8-K

    Report of unscheduled material events or corporate event

    View HTML
    8-K

    Report of unscheduled material events or corporate event

    View HTML

    Data provided by Kaleidoscope.

    NASDAQ: VCEL

    $59.50 -0.03 (-0.05%)
    Day High: $60.13
    Day Low: $57.58
    Volume: 465,589
    4:00 PM EST on
    Jan 10, 2025
    Data Provided by Refinitiv. Minimum 15 minutes delayed.